NCT02403531View on ClinicalTrials.gov

Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

September 6, 2017

Study Completion Date

May 30, 2020

Conditions
Neoplasms
Interventions
DRUG

Docetaxel

Include brand names, serial numbers and code names to improve search results on the ClinicalTrials.gov web site.

DRUG

Cisplatin

Include brand names, serial numbers and code names to improve search results on the ClinicalTrials.gov web site.

RADIATION

Radiotherapy

definitive radiotherapy

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Mian XI

OTHER

NCT02403531 - Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal Cancer | Biotech Hunter | Biotech Hunter